Advertisement

International Journal of Clinical Pharmacy

, Volume 40, Issue 5, pp 1189–1198 | Cite as

A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management

  • Johanna Freyer
  • Lysann Kasprick
  • Ralf Sultzer
  • Susanne Schiek
  • Thilo BertscheEmail author
Research Article
  • 177 Downloads

Abstract

Background Drug-related problems (DRPs) endanger geriatric patients’ safety. Especially a follow-up treatment with increased number of care transitions is a critical time for patients. Objective This study aimed at optimising medication therapy and the transfer of medication-related information to ambulatory care in geriatric rehabilitation patients. Setting German geriatric rehabilitation centre (GRC). Method A prospective, controlled intervention study was performed. Patients in the control group (CG) received standard care, those in the intervention group (IG) an additional dual pharmaceutical intervention: (i) medication review to optimise in-hospital medication and (ii) improvement of discharge letters for optimising transfer of medication-related information. Main outcome measure (i) Number of patients with at least one DRP at discharge and (ii) predefined quality criteria for the discharge letters. Results 150 patients were enrolled in CG and 163 in IG. (i) At discharge, 126 (84%) patients in the CG were affected by at least one DRP. In the IG, the number of affected patients decreased to 64 (39%, P < 0.05). (ii) In comparison to discharge letters in the CG, predefined quality criteria were improved in the IG. Following differences were measured (CG vs. IG, each P < 0.05): active ingredient indicated (60 vs. 99%), brand name indicated (60 vs. 96%), explanation of medication changes (47 vs. 68%), visualisation of explanations next to the discharge medication (26 vs. 91%) and recommended therapy duration for short-term medications (49 vs. 84%). Conclusion DRPs and incomplete discharge letters affected many patients. The dual intervention improved in-hospital medication therapy and optimised the transfer of medication-related information.

Keywords

Aged Clinical Pharmacist Drug-related problem Geriatric Rehabilitation Centre Germany Medication Review Patient Discharge Transitional Care 

Notes

Acknowledgements

We would like to thank all participating physicians and patients being involved in this study.

Funding

This study was financially supported by the HELIOS Kliniken GmbH (grant-ID: 003038). The source had no influence on the content and data interpretation of this study.

Conflicts of Interest

All authors declare that they have no conflict of interest concerning this paper.

References

  1. 1.
    Gesundheitsberichterstattung des Bundes. Diagnosedaten der Krankenhäuser ab 2000 (Eckdaten der vollstationären Patienten und Patientinnen). Gliederungsmerkmale: Jahre, Behandlungs-/Wohnort, ICD 10. [Healthmessages of the state. Details on diagnosis in hospitals since 2000 (core data of chronic patients). Sorting type: Year, place of treatment and living, ICD 10]. http://www.gbe-bund.de/oowa921install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=i&p_aid=4267392&nummer=550&p_sprache=D&p_indsp=-&p_aid=39855747. Accessed November 10 2017.
  2. 2.
    Healthcare Cost and Utilization Project (HCUP). In: HCUP facts and figures: statistics on hospital-based care in the United States, [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. Overview statistics for inpatient hospital stays. 2009. https://www.ncbi.nlm.nih.gov/books/NBK91986/. Accessed November 11 2017.
  3. 3.
    Australian Institute of Health and Welfare. Admitted patient care 2015–16: Australian hospital statistics. Health services series no. 75. Cat. no. HSE 185. Canberra: AIHW. 2017. https://www.aihw.gov.au/getmedia/3e1d7d7e-26d9-44fb-8549-aa30ccff100a/20742.pdf.aspx?inline=true. Accessed November 11 2017.
  4. 4.
    Bourgeois FT, Shannon MW, Valim C, Mandl K. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19(9):901–10.CrossRefGoogle Scholar
  5. 5.
    Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185–91.CrossRefGoogle Scholar
  6. 6.
    Baena MI, Faus MJ, Fajardo C, Lugue FM, Sierra F, Martinez-Olmos J, et al. Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol. 2006;62(5):387–93.CrossRefGoogle Scholar
  7. 7.
    Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6–14.CrossRefGoogle Scholar
  8. 8.
    Ahmad A, Mast MR, Nijpels G, Elders PJ, Dekker JM. Hugtenburg JG Identification of drug-related problems of elderly patients discharged from hospital. Patient Prefer Adherence. 2014;8:155–65.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Basey AJ, Krska J, Kennedy TD, Mackridge AJ. Prescribing errors on admission to hospital and their potential impact: a mixed-methods study. BMJ Qual Saf. 2014;23(1):17–25.CrossRefGoogle Scholar
  10. 10.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317–23.CrossRefGoogle Scholar
  11. 11.
    Belda-Rustarazo S, Cantero-Hinojosa J, Salmeron-Garcia A, Gonzalez-Garcia L, Cabeza-Barrera J, Galvez J. Medication reconciliation at admission and discharge: an analysis of prevalence and associated risk factors. Int J Clin Pract. 2015;69(11):1268–74.CrossRefGoogle Scholar
  12. 12.
    Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297:831–41.CrossRefGoogle Scholar
  13. 13.
    Van Walraven C, Seth R, Laupacis A. Dissemination of discharge summaries. Not reaching follow-up physicians. Can Fam Physician. 2002;48(4):737–42.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Garcia BH, Djønne BS, Skjold F, Mellingen EM, Aag TI. Quality of medication information in discharge summaries from hospitals: an audit of electronic patient records. Int J Clin Pharm. 2017;39(6):1331–7.CrossRefGoogle Scholar
  15. 15.
    Uitvlugt EB, Siegert CE, Janssen MJ, Nijpels G, Karapinar-Çarkit F. Completeness of medication-related information in discharge letters and post-discharge general practitioner overviews. Int J Clin Pharm. 2015;37(6):1206–12.CrossRefGoogle Scholar
  16. 16.
    Cornu P, Steurbaut S, Leysen T, De Baere E, Ligneel C, Mets T, et al. Discrepancies in medication information for the primary care physician and the geriatric patient at discharge. Ann Pharmacother. 2012;46(7–8):983–90.CrossRefGoogle Scholar
  17. 17.
    O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Cullinan S, O’Sullivan R, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31(6):471–81.CrossRefGoogle Scholar
  18. 18.
    Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013;8:703–9.CrossRefGoogle Scholar
  19. 19.
    Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257–65.CrossRefGoogle Scholar
  20. 20.
    Willeboordse F, Schellevis FG, Chau SH, Hugtenburg JG, Elders PJM. The effectiveness of optimized clinical medication reviews for geriatric patients: opti-med a cluster randomised controlled trial. Fam Pract. 2017;34(4):437–45.CrossRefGoogle Scholar
  21. 21.
    Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Providing systematic detailed information on medication upon hospital discharge as an important step towards improved transitional care. J Clin Pharm Ther. 2014;39:286–91.CrossRefGoogle Scholar
  22. 22.
    Greißing C, Buchal P, Kabitz HJ, Schuchmann M, Zantl N, Schiek S, et al. Medikation und Adhärenz nach stationärer Entlassung. [Medication and treatment adherence following hospital discharge]. Dtsch Arztebl Int. 2016;113:749–56.Google Scholar
  23. 23.
    Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2(5):314–23.CrossRefGoogle Scholar
  24. 24.
    Willoch K, Blix HS, Pedersen-Bjergaard AM, Eek AK, Reikvam A. Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm. 2012;34:382–8.CrossRefGoogle Scholar
  25. 25.
    The PCNE Classification V 7.0. http://www.pcne.org/upload/files/152_PCNE_classification_V7-0.pdf. Accessed November 11 2017.
  26. 26.
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefGoogle Scholar
  27. 27.
    Langebrake C, Kantelhardt P. DokuPIK—ein Dokumentationssystem für Medikationsfehler und Interventionen. [DokuPIK-A documenttation system for medication errors and interventions]. Krankenhauspharmazie. 2009;30:63–8.Google Scholar
  28. 28.
    Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Fick D, Semla T, Beizer J, Brandt N, Dombrowski R, DuBeau CE, et al. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31.CrossRefGoogle Scholar
  30. 30.
    CAVE Module der ABDA Datenbank—Internationale Arzneimittelinformationen für Fachkreise - © DACON GmbH, Bad Vilbel. pharmazie.com. [CAVE module of the ABDA Database—International drug information for professionals]. Accessed November 11 2017.Google Scholar
  31. 31.
    §115 c Absatz 1 Fortsetzung der Arzneimitteltherapie nach Krankenhausbehandlung, Sozialgesetzbuch (SGB V) Fünftes Buch Gesetzliche Krankversicherung, zuletzt geändert durch Art. 11 Abs 43 G v. 18.7.2017 I 2745 (Code of Social Law V). [Conituation of drug therapy after treatment in hospital].Google Scholar
  32. 32.
    PCNE Working group on medication review. http://www.pcne.org/working-groups/1/medication-review. Accessed November 19, 2017.
  33. 33.
    Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admissions in the elderly. Intern Med J. 2001;361:199–205.CrossRefGoogle Scholar
  34. 34.
    Thomas J, Coralic A, Ruegger M, Thompson-Moore N. Descriptive analysis of patient readmissions within 60 days due to medication-related events. Hosp Pharm. 2015;50:595–602.CrossRefGoogle Scholar
  35. 35.
    Blix HS, Viktil KK, Reikvam A, Moger TA, Hjemaas BJ, Pretsch P, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651–8.CrossRefGoogle Scholar
  36. 36.
    Ruiz-Millo O, Climente-Martí M, Galbis-Bernácer AM, Navarro-Sanz JR. Clinical impact of an interdisciplinary patient safety program for managing drug-related problems in a long-term care hospital. Int J Clin Pharm. 2017;39(6):1201–10.CrossRefGoogle Scholar
  37. 37.
    Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrade Med J. 2007;83:66–8.CrossRefGoogle Scholar
  38. 38.
    Schepisi R, Fusco S, Sganga F, Falcone B, Vetrano DL, Abbatecola A, et al. Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals. J Nutr Health Aging. 2016;20(6):665–70.CrossRefGoogle Scholar
  39. 39.
    Eusebi LH, Rabitti S, Artesiani ML, Gelli D, Montagnani M, Zagari RM, et al. Proton pump inhibitors: risks of long-term use. J Gastroenterol Hepatol. 2017;32(7):1295–302.CrossRefGoogle Scholar
  40. 40.
    Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, et al. Analysis of drug-related problems in three departments of a German University hospital. Int J Clin Pharm. 2016;38(1):119–26.CrossRefGoogle Scholar
  41. 41.
    Riordan DO, Walsh KA, Galvin R, Sinnott C, Kearney PM, Byrne S. The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: A systematic review. SAGE Open Med. 2016. eCollection.Google Scholar
  42. 42.
    Ensing HT, Stuijt CC, van den Bemt BJ, van Dooren AA, Karapinar-Çarkit F, Koster ES, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.PubMedGoogle Scholar
  43. 43.
    Freyer J, Hueter L, Kasprick L, Frese T, Sultzer R, Schiek S, et al. Drug-related problems in geriatric rehabilitation patients after discharge—A prevalence analysis and clinical case scenario-based pilot study. Res Social Adm Pharm. 2017 [Epub ahead of print].Google Scholar
  44. 44.
    Wilson S, Ruscoe W, Chapman M, Miller R. General practitioner-hospital communications: a review of discharge summaries. J Qual Clin Pract. 2001;21(4):104–8.CrossRefGoogle Scholar
  45. 45.
    Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165(16):1842–7.CrossRefGoogle Scholar
  46. 46.
    Adam H, Niebling WB, Schott G. The information about discharge medication: what do general practitioners need? Dtsch Med Wochenscr. 2015;140(8):e74–9.CrossRefGoogle Scholar
  47. 47.
    Karapinar F, van den Bemt PM, Zoer J, Nijpels G, Borgseede SD. Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic advice. Pharm World Sci. 2010;32(2):172–8.CrossRefGoogle Scholar
  48. 48.
    The Commonwealth Fund—International Health Care System Profiles. http://international.commonwealthfund.org/features/ehrs/. Accessed January 01 2018.
  49. 49.
    Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199–205.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Johanna Freyer
    • 1
  • Lysann Kasprick
    • 2
  • Ralf Sultzer
    • 2
    • 3
  • Susanne Schiek
    • 1
  • Thilo Bertsche
    • 1
    Email author
  1. 1.Drug Safety Center, University Hospital of Leipzig and Leipzig University and Department of Clinical PharmacyLeipzig UniversityLeipzigGermany
  2. 2.Geriatric Network (GeriNet) LeipzigLeipzigGermany
  3. 3.Sana Geriatric Centre Zwenkau (former: HELIOS Geriatric Centre Zwenkau)ZwenkauGermany

Personalised recommendations